1
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Can the Bad Guys Be Defeated?

Pages 113-115 | Published online: 11 Jun 2009

References

  • Haubeck H-D, Kolsch E. Isolation and characterization of in vitro and in vivo functions of a tumor-specific T suppressor cell clone from a BALB/c mouse bearing the syngeneic ADJ-PC-5 plasmacytoma. J Immunol 1985; 135: 4297–4301
  • North R J. Down-regulation of the antitumor immune response. Adv Cancer Res 1985; 45: 1–43
  • Greene M I. The genetic and cellular basis of regulation of the immune response to tumor antigens. Contemp Top Immunobiol 1980; 11: 81–116
  • Nagarkatti M, Kaplan A M. The role of suppressor T cells in BCNU-mediated rejection of a syngeneic tumor. J Immunol 1985; 135: 1510–1517
  • Hengst J CD, Mokyr M B, Dray S. Importance of timing of cyclophosphamide therapy of MOPC-315 tumor bearing mice. Cancer Res 1980; 40: 2135–2141
  • Shanahan T C, Ceglowski W S, Havas H F. Cellular changes and antitumor responses in the plasmacytoma-bearing mouse following cyclophosphamide treatment. Cancer Res 1985; 45: 6463–6470
  • Hengst J CD, Mokyr M B, Dray S. Cooperation between cyclophosphamide tumoricidal activity and host antitumor immunity in the cure of mice bearing large MOPC-315 tumors. Cancer Res 1981; 41: 2163–2167
  • Mokyr M B, Hengst J CD, Dray S. The role of antitumor immunity in cyclophosphamide-induced rejection of subcutaneous nonpalpable MOPC-315 tumors. Cancer Res 1982; 42: 974–979
  • Mokyr M B, Dray S. Interplay between the toxic effects of anticancer drugs and host antitumor immunity in cancer therapy. Cancer Invest 1987; 5: 31–38
  • Miura T, Ghanta V K, Hiramoto R N. Host response to myeloma: I. Induction of cytotoxic and suppressor T cells by in vivo immunization with MOPC 104E plasmacytoma. Cancer Inves 1987; 6: 1
  • Berd D, Maguire H C, Mastrangelo M J. Induction of cell-mediated immunity to autologous melanoma cell and regression of metastases after treatment with melanoma cell vaccine preceded by cyclophosphamide. Cancer Res 1986; 46: 2572–2577

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.